Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus

Systemic Lupus Erythematosus

Impact of multiple sclerosis on quality of life: Comparison with systemic lupus erythematosus

Clin Neurol Neurosurg.

Carnero Contentti E, Genco ND, Hryb JP, Caspi M, Chiganer E, Di Pace JL, López PA, Lessa C, Caride A, Perassolo M

doi: 10.1016/

Rheumatoid ArthritisSystemic Lupus Erythematosus

Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission

Clin Exp Rheumatol.

Pascual-Ramos V, Contreras-Yáñez I, Valencia-Quiñones KR, Romero-Díaz J

Systemic Lupus Erythematosus

Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis

J Rheumatol.

Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, Keeling S, Pope JE, Fifi-Mah A1, Bourré-Tessier J

doi: 10.3899/jrheum.170837.

Autoimmune DiseaseSystemic Lupus Erythematosus

Elevated Semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.

Clin Exp Immunol.

Du Y, Wu X, Chen M, Wang W, Xv W, Ye L, Wu D, Xue J, Sun W, Luo J, Wu H

doi: 10.1111/cei.12924.

Systemic Lupus Erythematosus

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Arthritis Res Ther.

Sohrabian A, Parodis I, Carlströmer-Berthén N, Frodlund M, Jönsen A, Zickert A, Sjöwall C, Bengtsson AA, Gunnarsson I, Rönnelid J

doi: 10.1186/s13075-019-2056-y.

Systemic Lupus Erythematosus

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus

Front Immunol.

Nehring J, Schirmbeck LA, Friebus-Kardash J, Dubler D, Huynh-Do U, Chizzolini C, Ribi C, Trendelenburg M

doi: 10.3389/fimmu.

Systemic Lupus Erythematosus

Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Program

Arthritis Care Res (Hoboken).

Charoenwoodhipong P, Harlow SD, Marder W, Hassett AL, McCune WJ, Gordon C, Helmick CG, Barbour KE, Wang L, Mancuso P, Somers EC, Zick SM

doi: 10.1002/acr.23925.

Systemic Lupus Erythematosus

Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome

Rheumatology (Oxford).

Blokland SLM, van den Hoogen LL, Leijten EFA, Hartgring SAY, Fritsch R, Kruize AA, van Roon JAG, Radstake TRDJ

doi: 10.1093/rheumatology/kez116.

Systemic Lupus Erythematosus

Two shared immune cell signatures stratify patients with Sjögren's syndrome and systemic lupus erythematosus with potential therapeutic implications

Arthritis Rheumatol

Martin-Gutierrez L, Peng J, Thompson NL, Robinson GA, Naja M, Peckham H, Wu W, J'bari H, Ahwireng N, Waddington KE, Bradford CM, Varnier G, Gandhi A, Radmore R, Gupta V, Isenberg DA, Jury EC, Ciurtin C

doi: 10.1002/art.41708

Related content

Impact of multiple sclerosis on quality of life: Comparison with systemic lupus erythematosus

Rheumatoid arthritis patients achieved better quality of life than systemic lupus erythematosus patients at sustained remission

Monitoring of Osteonecrosis in Systemic Lupus Erythematosus Patients: A Systematic Review and Metaanalysis

Elevated Semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus

Autoantibodies Against Albumin in Patients With Systemic Lupus Erythematosus

Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Program

Increased expression of Fas on group 2 and 3 innate lymphoid cells is associated with an interferon signature in systemic lupus erythematosus and Sjögren's syndrome

Two shared immune cell signatures stratify patients with Sjögren's syndrome and systemic lupus erythematosus with potential therapeutic implications